0
3
Short answer: The Revised Schedule M extension for MSME pharmaceutical manufacturers with turnover up to Rs 250 crore ran to 31 December 2025 under G.S.R. 127(E) dated 11 February 2025, and from 1 January 2026 manufacturers who did not apply became s..
Showing 1 to 1 of 1 (1 Pages)